Financials GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-06-12 pm EDT 5-day change 1st Jan Change
75.97 USD +1.65% Intraday chart for GE HealthCare Technologies Inc. -1.29% -1.75%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 26,546 35,199 34,678 - -
Enterprise Value (EV) 1 33,350 42,137 39,895 37,841 35,488
P/E ratio 14 x 25.4 x 18.7 x 16.5 x 14.7 x
Yield - - 0.12% 0.19% 0.26%
Capitalization / Revenue 1.45 x 1.8 x 1.72 x 1.64 x 1.56 x
EV / Revenue 1.82 x 2.16 x 1.98 x 1.79 x 1.59 x
EV / EBITDA 10.6 x 11.8 x 10.8 x 9.53 x 8.34 x
EV / FCF - 24.6 x 21.7 x 23.3 x 11.4 x
FCF Yield - 4.07% 4.6% 4.3% 8.74%
Price to Book - 4.94 x 4.1 x 3.24 x 2.7 x
Nbr of stocks (in thousands) 454,710 455,243 456,465 - -
Reference price 2 58.38 77.32 75.97 75.97 75.97
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 18,341 19,552 20,165 21,160 22,286
EBITDA 1 3,155 3,566 3,678 3,970 4,257
EBIT 1 2,522 2,956 3,163 3,446 3,775
Operating Margin 13.75% 15.12% 15.69% 16.28% 16.94%
Earnings before Tax (EBT) 1 2,512 2,361 2,551 2,889 3,223
Net income 1 1,916 1,568 1,858 2,119 2,360
Net margin 10.45% 8.02% 9.21% 10.01% 10.59%
EPS 2 4.180 3.040 4.059 4.605 5.175
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
FCF margin - 8.77% 9.11% 7.69% 13.92%
FCF Conversion (EBITDA) - 48.07% 49.94% 40.97% 72.89%
FCF Conversion (Net income) - 109.31% 98.86% 76.76% 131.51%
Dividend per Share 2 - - 0.0933 0.1466 0.2000
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,576 4,938 4,707 4,817 4,822 5,206 4,650 4,883 5,067 5,542 4,911 5,150
EBITDA 1 - - - - 808 981 749 893.6 962.3 1,096 910.4 -
EBIT 1 - 777 664 711 744 837 681 738.5 807.1 945 751.6 807.3
Operating Margin - 15.74% 14.11% 14.76% 15.43% 16.08% 14.65% 15.12% 15.93% 17.05% 15.3% 15.67%
Earnings before Tax (EBT) 1 - 718 546 570 636 609 512 587 671.3 800.3 603 660.7
Net income 1 487 554 189 418 375 403 374 424.1 479.3 581.4 462.8 491.7
Net margin 10.64% 11.22% 4.02% 8.68% 7.78% 7.74% 8.04% 8.69% 9.46% 10.49% 9.42% 9.55%
EPS 2 - 1.210 0.4100 0.9100 0.8200 0.8800 0.8100 0.9125 1.031 1.254 0.9825 1.067
Dividend per Share - - - 0.0600 0.0300 - - - - - - -
Announcement Date 11/7/22 1/30/23 4/25/23 7/25/23 10/31/23 2/6/24 4/30/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 6,804 6,938 5,217 3,164 810
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 2.157 x 1.946 x 1.418 x 0.7969 x 0.1904 x
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
ROE (net income / shareholders' equity) - 19% 24.7% 24.2% 22.6%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - 15.70 18.50 23.50 28.10
Cash Flow per Share 2 - 4.590 4.840 5.970 6.870
Capex 1 310 387 393 415 426
Capex / Sales 1.69% 1.98% 1.95% 1.96% 1.91%
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
75.97 USD
Average target price
92.74 USD
Spread / Average Target
+22.07%
Consensus
  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. Financials GE HealthCare Technologies Inc.